Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report
- 期刊名称BMC Nephrology
- 作者Jeon, So-Yeon; Lee, Na-Ri; Yim, Chang-Yeol
- 卷第20卷
- 期第1期
- 电子ISSN1471-2369
- 文件大小783.09KB
- 发表时间2019-12
- DOI10.1186/s12882-018-1181-1
Multiscale modeling for cancer radiotherapiesSurdutovich, Eugene; Solov’yov, Andrey V. · Cancer Nanotechnology · 2019
From basics to clinic: Cancer NanotechnologyCurrell, Fred; Curley, Steven; Krpetić, Željka; Bellringer, Mark · Cancer Nanotechnology · 2017
Biological mechanisms of gold nanoparticle radiosensitizationRosa, Soraia; Connolly, Chris; Schettino, Giuseppe; Butterworth, Karl T.; Prise, Kevin M. · Cancer Nanotechnology · 2017
Application of nanotechnology to cancer radiotherapyMi, Yu; Shao, Zhiying; Vang, Johnny; Kaidar-Person, Orit; Wang, Andrew Z. · Cancer Nanotechnology · 2016
Gold nanoparticle mediated combined cancer therapyYang, Celina; Bromma, Kyle; Di Ciano-Oliveira, Caterina; Zafarana, Gaetano; van Prooijen, Monique; Chithrani, Devika B. · Cancer Nanotechnology · 2018
Enhanced nanoparticle delivery exploiting tumour-responsive formulationsBennie, Lindsey A.; McCarthy, Helen O.; Coulter, Jonathan A. · Cancer Nanotechnology · 2018
Could nanoparticle corona characterization help for biological consequence prediction?Brun, Emilie; Sicard – Roselli, Cécile · Cancer Nanotechnology · 2014
DNA vaccination for prostate cancer: key concepts and considerationsCole, Grace; McCaffrey, Joanne; Ali, Ahlam A.; McCarthy, Helen O. · Cancer Nanotechnology · 2015